We are live on ! Find out more
MF

Magnetar Financial Portfolio holdings

AUM $9.84B
1-Year Est. Return 190.64%
This Fund
S&P 500
This Quarter Est. Return
+6.33%
1 Year Est. Return
+190.64%
3 Year Est. Return
+293.18%
5 Year Est. Return
+491.79%
10 Year Est. Return
+5,174.28%
AUM
$4.62B
AUM Growth
-$179M
Cap. Flow
-$2.12B
Cap. Flow %
-45.83%
Top 10 Hldgs %
20.62%
Holding
756
New
266
Increased
123
Reduced
74
Closed
249

Top Buys

Rank Stock Value
1
K
Kellanova
K
+$71M
2
MCK icon
McKesson
MCK
+$54.9M
3
TELL
Tellurian Inc.
TELL
+$41.7M
4
FYBR
Frontier Communications
FYBR
+$39.6M
5
AZN icon
AstraZeneca
AZN
+$38.7M

Top Sells

Rank Stock Value
1
NVS icon
Novartis
NVS
+$139M
2
ZBH icon
Zimmer Biomet
ZBH
+$125M
3
CVII
Churchill Capital Corp VII Class A Common Stock
CVII
+$89.5M
4
BDX icon
Becton Dickinson
BDX
+$87M
5
ABT icon
Abbott
ABT
+$85.5M

Sector Composition

Rank Sector Weight
1 Healthcare 35.44%
2 Technology 10.1%
3 Energy 7.35%
4 Financials 6.6%
5 Industrials 6.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OMCL icon
401
Omnicell
OMCL
$1.69B
$253K 0.01%
+5,803
New +$219K
DOCU
402
DocuSign
DOCU
$10.4B
$250K 0.01%
+4,032
New +$226K
NYT icon
403
New York Times
NYT
$12.3B
$250K 0.01%
4,491
+343
+8% +$18.5K
CPRX
404
DELISTED
Catalyst Pharmaceutical
CPRX
$249K 0.01%
+12,500
New +$232K
BHE icon
405
Benchmark Electronics
BHE
$2.85B
$247K 0.01%
+5,566
New +$232K
FFIC
406
DELISTED
Flushing Financial
FFIC
$247K 0.01%
+16,919
New +$238K
IRMD icon
407
iRadimed
IRMD
$1.22B
$246K 0.01%
4,890
-1,576
-24% -$72.7K
PHR icon
408
Phreesia
PHR
$656M
$244K 0.01%
+10,722
New +$251K
AMG icon
409
Affiliated Managers Group
AMG
$9.65B
$244K 0.01%
+1,374
New +$233K
HP icon
410
Helmerich & Payne
HP
$3.37B
$241K 0.01%
+7,921
New +$274K
FWONK icon
411
Liberty Media Series C
FWONK
$25.1B
$241K 0.01%
3,110
-84
-3% -$6.47K
AI icon
412
C3.ai
AI
$1.41B
$240K 0.01%
9,910
+1,951
+25% +$49.6K
BMRN icon
413
BioMarin Pharmaceuticals
BMRN
$11.7B
$239K 0.01%
3,404
-5,412
-61% -$452K
CNK icon
414
Cinemark Holdings
CNK
$4.19B
$238K 0.01%
+8,534
New +$217K
ANF icon
415
Abercrombie & Fitch
ANF
$4.45B
$236K 0.01%
+1,690
New +$257K
FOLD
416
DELISTED
Amicus Therapeutics
FOLD
$236K 0.01%
+22,077
New +$240K
AMR icon
417
Alpha Metallurgical Resources
AMR
$1.82B
$232K 0.01%
+984
New +$251K
SEMR
418
DELISTED
Semrush
SEMR
$231K 0.01%
+14,720
New +$206K
BRZE icon
419
Braze
BRZE
$2.82B
$230K 0.01%
7,099
-14,466
-67% -$571K
AERT
420
Aeries Technology
AERT
$36.2M
$229K 0.01%
12,460
-3,165
-20% -$56.4K
MTX icon
421
Minerals Technologies
MTX
$2.25B
$226K ﹤0.01%
+2,927
New +$226K
BIIB icon
422
Biogen
BIIB
$30.7B
$225K ﹤0.01%
+1,160
New +$243K
HXL icon
423
Hexcel
HXL
$7.78B
$224K ﹤0.01%
+3,624
New +$228K
DCBO
424
Docebo
DCBO
$528M
$224K ﹤0.01%
+5,064
New +$207K
CRWD icon
425
CrowdStrike
CRWD
$189B
$223K ﹤0.01%
+3,180
New +$226K
15 16
17
18 19

Similar funds

HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $9.79B AUM 20.6% 1-Year Est. Return
URS
Utah Retirement Systems Salt Lake City, Utah $9.78B AUM 28.72% 1-Year Est. Return
FPAS
Focus Partners Advisor Solutions Saint Louis, Missouri $9.92B AUM 21.52% 1-Year Est. Return
CCM
Cullen Capital Management New York $9.75B AUM 21.81% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return

Magnetar Financial's Q3 2024 Portfolio in Review

As of Q3 2024, Magnetar Financial held 756 positions worth $4.62B, down 3.7% from $4.8B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Magnetar Financial withdrew a net $2.12B in Q3 2024, closing 249 positions and reducing 74 holdings. Its most notable exit was Novartis, an estimated $139M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, down from 48% a quarter earlier, followed by Technology and Energy.

Against the trend, Magnetar Financial opened a new position in Kellanova worth $80.5M.

  • Magnetar Financial's largest Q3 2024 buy was Kellanova: 997,792 shares worth $80.5M.
  • Magnetar Financial added most to McKesson in Q3 2024, an estimated $54.9M increase.
  • Magnetar Financial's biggest Q3 2024 reduction was Zimmer Biomet, cutting an estimated $125M.
  • Magnetar Financial fully exited Novartis in Q3 2024, selling an estimated $139M.
  • Magnetar Financial's ten largest holdings make up 21% of its $4.62B portfolio in Q3 2024.
  • Magnetar Financial opened 266 new positions and closed 249 in Q3 2024.
  • Magnetar Financial's portfolio value fell 3.7% quarter-over-quarter to $4.62B.

Based on Magnetar Financial's 13F filing for Q3 2024, filed 13 Nov 2024.